Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging.
about
Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma PatientsHigh-resolution whole-brain DCE-MRI using constrained reconstruction: Prospective clinical evaluation in brain tumor patientsMR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps.Current Clinical Brain Tumor ImagingDynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.Quantitative sodium MR imaging: A review of its evolving role in medicine.The impact of reliable prebolus T 1 measurements or a fixed T 1 value in the assessment of glioma patients with dynamic contrast enhancing MRI.The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches.Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and TemozolomiTreatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.Regarding "Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study".Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.Correlation of dynamic contrast-enhanced MRI derived volume transfer constant with histological angiogenic markers in high-grade gliomas.Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.Differential diagnosis of oligodendroglial and astrocytic tumors using imaging results: the added value of perfusion MR imaging.Contrast-Enhanced Perfusion MR Imaging to Differentiate Between Recurrent/Residual Brain Neoplasms and Radiation Necrosis
P2860
Q28066044-E14C3875-EBCE-4ED8-A850-7F5B91FA2436Q28600963-D546D221-1D88-40EE-A4DD-412C7C35BB29Q36097886-7B784892-8BA4-45C3-AD15-0C8587D98271Q36337934-802A0220-EBCB-4C9A-8153-27647961F08CQ36367172-4EB8E613-8B1F-4083-98B4-CC5BEDFF3628Q36501577-51385179-7D81-4265-B086-2E50A5591A4AQ36893250-32F63E7B-4889-4078-8BF8-EAE41E03EF84Q37496863-975CC2B2-8B41-4435-A093-53459591B3FFQ39021644-33133D32-C8D3-4A06-92DB-E52C811AE3F4Q40261840-B8CC5526-E1BE-4BE1-A1D1-EE69FA3A28D0Q41416115-15ABAC77-F6C3-433F-904D-14592623367CQ43376098-49916EC0-CD11-4D26-86F6-6A80C0117025Q45945185-C4CC9414-09ED-453D-9C19-2E741907D0C5Q47406548-9F4EC028-F900-488A-9C91-1C0A43E19C82Q48155295-B70504B2-D722-4B36-930C-3532B6A88DDFQ48184622-5EEAB1BC-D467-4A32-B391-C76E59E9A890Q48225182-A682482C-F3C8-472F-941B-955ED699DFEAQ50057018-FD246268-AC85-4782-AA73-FE3A0AA8938AQ50237668-B915B927-6C0D-482B-A0C6-91621209003DQ51079367-64972155-1745-4B92-B4DE-17335D2E2EB6Q52093540-3DC29EA9-A51A-42E8-B153-82AA02F9BFDEQ55528783-06DE9286-B8B2-4A80-A78D-BB74FA077BB0
P2860
Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Glioblastoma treated with conc ...... contrast-enhanced MR imaging.
@ast
Glioblastoma treated with conc ...... contrast-enhanced MR imaging.
@en
type
label
Glioblastoma treated with conc ...... contrast-enhanced MR imaging.
@ast
Glioblastoma treated with conc ...... contrast-enhanced MR imaging.
@en
prefLabel
Glioblastoma treated with conc ...... contrast-enhanced MR imaging.
@ast
Glioblastoma treated with conc ...... contrast-enhanced MR imaging.
@en
P2093
P50
P356
P1433
P1476
Glioblastoma treated with conc ...... contrast-enhanced MR imaging.
@en
P2093
Chul-Ho Sohn
Chul-Kee Park
Il Han Kim
Se-Hoon Lee
Sung-Hye Park
Tae Min Kim
P304
P356
10.1148/RADIOL.14132632
P407
P577
2014-10-21T00:00:00Z